Maintenance Therapy With Olaparib Found To Result In Clinically Meaningful Improvement In OS In Women With Platinum-Sensitive, BRCA 1/2-Mutated, Relapsed Ovarian Cancer

Cancer Therapy Advisor (4/19, Blevins Primeau) reports, “Maintenance therapy with olaparib was found to result in a clinically meaningful, but not statistically significant, improvement in overall survival compared with placebo among women with platinum-sensitive, BRCA 1/2-mutated, relapsed ovarian cancer, according to” a study. The findings were published in The Lancet Oncology.